Vanguard Group Inc Eton Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,063,707 shares of ETON stock, worth $16.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,063,707

Previous 1,027,688 3.5%

Holding current value

$16.7 Million

Previous $6.17 Million 126.84%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$5.9 - $13.15 $212,512 - $473,649	36,019 Added 3.5%	1,063,707 $14 Million
Q4 2023 Feb 14, 2024	BUY	$3.45 - $4.66 $176,819 - $238,834	51,252 Added 5.25%	1,027,688 $4.5 Million
Q2 2023 Aug 14, 2023	SELL	$3.32 - $4.04 $12,772 - $15,541	-3,847 Reduced 0.39%	976,436 $3.41 Million
Q1 2023 May 15, 2023	BUY	$2.89 - $4.1 $159,470 - $226,237	55,180 Added 5.96%	980,283 $3.77 Million
Q4 2022 Feb 10, 2023	BUY	$2.02 - $3.25 $785 - $1,264	389 Added 0.04%	925,103 $2.61 Million
Q3 2022 Nov 14, 2022	BUY	$2.04 - $3.03 $105,759 - $157,084	51,843 Added 5.94%	924,714 $1.94 Million
Q1 2022 May 13, 2022	SELL	$3.43 - $4.69 $18,971 - $25,940	-5,531 Reduced 0.63%	872,871 $3.81 Million
Q4 2021 Feb 14, 2022	BUY	$3.66 - $6.59 $43,689 - $78,664	11,937 Added 1.38%	878,402 $3.77 Million
Q3 2021 Nov 12, 2021	BUY	$4.2 - $6.26 $20,685 - $30,830	4,925 Added 0.57%	866,465 $4.37 Million
Q2 2021 Aug 13, 2021	BUY	$5.71 - $8.85 $4.92 Million - $7.62 Million	861,540 New	861,540 $5.31 Million

Others Institutions Holding ETON

# of Institutions

Shares Held

13.1M

Call Options Held

284K

Put Options Held

4.2K

View Full List

About Eton Pharmaceuticals, Inc.

Ticker ETON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,297,000
Market Cap $397M
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...

More about ETON

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Eton Pharmaceuticals, Inc. Transaction History